Aristo Bio-Tech

Market Cap: Micro Cap
Industry: Pesticides & Agrochemicals
ISIN: INE082101010
NSEID: ARISTO
BSEID:

INR

112.00

-4.95 (-4.23%)

BSENSE

Dec 05

BSE+NSE Vol: 800

{
  "main_header": {
    "sid": 1003785,
    "name": "Aristo Bio-Tech",
    "stock_name": "Aristo Bio-Tech",
    "full_name": "Aristo Bio-Tech & Lifescience Ltd",
    "name_url": "stocks-analysis/aristo-bio-tech",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "112.00",
    "chg": -4.95,
    "chgp": "-4.23%",
    "dir": -1,
    "prev_price": "116.95",
    "mcapval": "80.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ARISTO",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE082101010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 800,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aristo-bio-tech-1003785-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3722297",
        "imagepath": "",
        "date": "2025-11-22 01:28:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance Compared to Benchmarks</strong></p>\n<p>Aristo Bio-Tech’s stock has experienced a significant decline over multiple timeframes when compared with the broader Sensex index. Over the past week, the stock fell by 5.77%, whereas the Sensex gained 0.61%. This negative trend intensified over the last month, with the stock dropping 9.26% against the Sensex’s modest 0.77% rise. Year-to-date figures further highlight the divergence: Aristo Bio-Tech is down 7.89%, while the Sensex has advanced by 10.25%. Over the last year, the stock’s decline deepened to 19.12%, contrasting sharply with the Sensex’s 11.64% gain. These figures indicate that the stock has underperformed the benchmark consistently, signalling investor caution or negative sentiment specific to the company or its s..."
      },
      {
        "title": "How has been the historical performance of Aristo Bio-Tech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-aristo-bio-tech-3704174",
        "imagepath": "",
        "date": "2025-11-15 00:27:39",
        "description": "Answer:\nThe historical performance of Aristo Bio-Tech shows a consistent growth trajectory in net sales and profitability over the past five years.\n\nBreakdown:\nAristo Bio-Tech's net sales have increased significantly from INR 165.76 crore in March 2022 to INR 318.09 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar pattern, rising from INR 167.22 crore in March 2021 to INR 318.09 crore in March 2025. However, raw material costs have also escalated, reaching INR 295.60 crore in March 2025, which has impacted the operating profit margin, which decreased from 4.0% in March 2023 to 2.91% in March 2025. Despite this, the operating profit (PBDIT) has shown improvement, growing from INR 4.36 crore in March 2021 to INR 9.72 crore in March 2025. Profit before tax has also increased, reaching INR 5.47 crore in March 2025, while profit after tax rose to INR 4.06 crore..."
      },
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3653987",
        "imagepath": "",
        "date": "2025-10-29 01:57:38",
        "description": "As of 28-Oct, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 125.05, which reflects a decrease of 4.95 or 3.81%. The stock has underperformed its sector by 4.71% today, and its delivery volume has significantly dropped by 54.55% compared to the 5-day average, indicating falling investor participation. Additionally, while the stock is above its 200-day moving average, it is below the 5-day, 20-day, 50-day, and 100-day moving averages. Over the past week, the stock has decreased by 7.37%, and it has also shown negative returns over the past month and year, with declines of 9.25% and 7.81%, respectively.\n\nIn the broader market context, the Sensex has shown a positive return of 0.26% over the past week and 5.20% over the past month, contrasting sharply with Aristo Bio-Tech's negative performance. The stock's year-to-date return is also negative at -5.98%, while the ..."
      },
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3584130",
        "imagepath": "",
        "date": "2025-09-30 23:29:02",
        "description": "As of 30-Sep, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 132.70, reflecting an increase of 6.5, or 5.15%. The stock has shown a performance today that outperformed its sector by 5.26%. However, it is important to note that the delivery volume has significantly decreased, falling by 68.75% against the 5-day average, indicating a decline in investor participation. In terms of returns, the stock has performed positively over the past month with a gain of 10.03%, while it has seen a slight decline of 0.23% year-to-date. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, although it is below the 5-day moving average.\n\nBroader market context shows that while Aristo Bio-Tech has outperformed the Sensex in the short term, with a 1-week decline of 3.70% compared to the Sensex's 2.22%, it has still managed to achieve a positive return over the past mont..."
      },
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3580880",
        "imagepath": "",
        "date": "2025-09-29 23:38:41",
        "description": "As of 29-Sep, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 126.20, which reflects a decrease of 11.6 points or 8.42%. The stock has underperformed its sector by 8.19% today, and while it is higher than the 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day and 20-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 75% compared to the 5-day average. Over the past week, the stock has decreased by 8.42%, contrasting with a modest increase of 4.64% over the past month.\n\nIn the broader market context, the Sensex has declined by 2.25% over the past week, indicating that while Aristo Bio-Tech is underperforming, the overall market is also facing challenges. Year-to-date, the stock has dropped by 5.11%, while the Sensex has gained 4.19%, further highlighting the stock's s..."
      },
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3568516",
        "imagepath": "",
        "date": "2025-09-24 23:32:34",
        "description": "As of 24-Sep, Aristo Bio-Tech & Lifescience Ltd is currently priced at 137.80, showing no change (0.00%). The stock has outperformed its sector by 0.32% today, although it has experienced a significant decline in investor participation, with delivery volume dropping by 75% compared to the 5-day average. Over the past month, the stock has increased by 24.03%, while year-to-date it has risen by 3.61%. However, the stock's performance over the last week shows a slight decline of 0.86%. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, but it is below its 5-day moving average, indicating mixed signals regarding its short-term momentum.\n\nIn the broader market context, the Sensex has decreased by 1.08% over the past week, which suggests that while Aristo Bio-Tech has faced some challenges, it has managed to perform relatively better than the benchmark. Year-to-date, the Sensex h..."
      },
      {
        "title": "Is Aristo Bio-Tech overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-aristo-bio-tech-overvalued-or-undervalued-3563333",
        "imagepath": "",
        "date": "2025-09-24 08:08:14",
        "description": "As of 23 September 2025, the valuation grade for Aristo Bio-Tech has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is considered overvalued based on its current metrics. Key ratios include a PE Ratio of 23.11, an EV to EBITDA of 12.36, and a PEG Ratio of 5.63, all of which suggest that the stock is trading at a premium compared to its earnings growth potential.\n\nIn comparison to peers, Aristo Bio-Tech's PE Ratio is notably lower than UPL's 38.05 and P I Industries' 34.2, both of which are categorized as attractive or very expensive, respectively. Additionally, while the company has shown a strong one-year return of 35.1%, outperforming the Sensex's decline of 2.97%, the overall valuation metrics suggest that it is not justified at its current price level of 137.80...."
      },
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3562496",
        "imagepath": "",
        "date": "2025-09-23 23:43:18",
        "description": "As of 23-Sep, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 137.80, showing no change (0.00%). The stock has outperformed its sector by 1.2% today, but it has experienced a decline of 0.86% over the past week. In terms of moving averages, the stock is performing higher than the 20-day, 50-day, 100-day, and 200-day moving averages, although it is lower than the 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume on 22 September falling by 75% compared to the 5-day average. The stock's year-to-date return stands at 3.61%, while its one-year return is notably higher at 35.10%. Unfortunately, there is no information available regarding positive or negative factors affecting the stock.\n\nBroader market context indicates that while Aristo Bio-Tech has shown a strong performance over the past month with a return of 24.03%, the benchmark ..."
      },
      {
        "title": "Is Aristo Bio-Tech overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-aristo-bio-tech-overvalued-or-undervalued-3556546",
        "imagepath": "",
        "date": "2025-09-23 08:07:04",
        "description": "As of 22 September 2025, the valuation grade for Aristo Bio-Tech has moved from very expensive to expensive, indicating a slight improvement in its perceived value. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 23.11, an EV to EBITDA of 12.36, and a PEG Ratio of 5.63, which suggest that the stock is trading at a premium compared to its earnings growth potential.\n\nIn comparison to its peers, Aristo Bio-Tech's PE Ratio is significantly lower than that of UPL, which stands at 38.29, while it is higher than Dhanuka Agritech's PE of 23.75. This places Aristo in a challenging position within the industry, as its valuation does not align favorably with its growth prospects. Additionally, while the stock has outperformed the Sensex over the past year with a return of 26.42% compared to the Sensex's -2.28%, the overall valuation still suggests that Ar..."
      }
    ],
    "total": 84,
    "sid": "1003785",
    "stock_news_url": "https://www.marketsmojo.com/news/aristo-bio-tech-lifescience-1003785"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aristo Bio-Tech & Lifescience Ltd has declared <strong>5%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Aristo Bio-Tech falling/rising?

2025-11-22 01:28:56

Recent Price Performance Compared to Benchmarks

Aristo Bio-Tech’s stock has experienced a significant decline over multiple timeframes when compared with the broader Sensex index. Over the past week, the stock fell by 5.77%, whereas the Sensex gained 0.61%. This negative trend intensified over the last month, with the stock dropping 9.26% against the Sensex’s modest 0.77% rise. Year-to-date figures further highlight the divergence: Aristo Bio-Tech is down 7.89%, while the Sensex has advanced by 10.25%. Over the last year, the stock’s decline deepened to 19.12%, contrasting sharply with the Sensex’s 11.64% gain. These figures indicate that the stock has underperformed the benchmark consistently, signalling investor caution or negative sentiment specific to the company or its s...

How has been the historical performance of Aristo Bio-Tech?

2025-11-15 00:27:39

Answer: The historical performance of Aristo Bio-Tech shows a consistent growth trajectory in net sales and profitability over the past five years. Breakdown: Aristo Bio-Tech's net sales have increased significantly from INR 165.76 crore in March 2022 to INR 318.09 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar pattern, rising from INR 167.22 crore in March 2021 to INR 318.09 crore in March 2025. However, raw material costs have also escalated, reaching INR 295.60 crore in March 2025, which has impacted the operating profit margin, which decreased from 4.0% in March 2023 to 2.91% in March 2025. Despite this, the operating profit (PBDIT) has shown improvement, growing from INR 4.36 crore in March 2021 to INR 9.72 crore in March 2025. Profit before tax has also increased, reaching INR 5.47 crore in March 2025, while profit after tax rose to INR 4.06 crore...

Why is Aristo Bio-Tech falling/rising?

2025-10-29 01:57:38

As of 28-Oct, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 125.05, which reflects a decrease of 4.95 or 3.81%. The stock has underperformed its sector by 4.71% today, and its delivery volume has significantly dropped by 54.55% compared to the 5-day average, indicating falling investor participation. Additionally, while the stock is above its 200-day moving average, it is below the 5-day, 20-day, 50-day, and 100-day moving averages. Over the past week, the stock has decreased by 7.37%, and it has also shown negative returns over the past month and year, with declines of 9.25% and 7.81%, respectively. In the broader market context, the Sensex has shown a positive return of 0.26% over the past week and 5.20% over the past month, contrasting sharply with Aristo Bio-Tech's negative performance. The stock's year-to-date return is also negative at -5.98%, while the ...

Why is Aristo Bio-Tech falling/rising?

2025-09-30 23:29:02

As of 30-Sep, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 132.70, reflecting an increase of 6.5, or 5.15%. The stock has shown a performance today that outperformed its sector by 5.26%. However, it is important to note that the delivery volume has significantly decreased, falling by 68.75% against the 5-day average, indicating a decline in investor participation. In terms of returns, the stock has performed positively over the past month with a gain of 10.03%, while it has seen a slight decline of 0.23% year-to-date. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, although it is below the 5-day moving average. Broader market context shows that while Aristo Bio-Tech has outperformed the Sensex in the short term, with a 1-week decline of 3.70% compared to the Sensex's 2.22%, it has still managed to achieve a positive return over the past mont...

Why is Aristo Bio-Tech falling/rising?

2025-09-29 23:38:41

As of 29-Sep, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 126.20, which reflects a decrease of 11.6 points or 8.42%. The stock has underperformed its sector by 8.19% today, and while it is higher than the 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day and 20-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 75% compared to the 5-day average. Over the past week, the stock has decreased by 8.42%, contrasting with a modest increase of 4.64% over the past month. In the broader market context, the Sensex has declined by 2.25% over the past week, indicating that while Aristo Bio-Tech is underperforming, the overall market is also facing challenges. Year-to-date, the stock has dropped by 5.11%, while the Sensex has gained 4.19%, further highlighting the stock's s...

Why is Aristo Bio-Tech falling/rising?

2025-09-24 23:32:34

As of 24-Sep, Aristo Bio-Tech & Lifescience Ltd is currently priced at 137.80, showing no change (0.00%). The stock has outperformed its sector by 0.32% today, although it has experienced a significant decline in investor participation, with delivery volume dropping by 75% compared to the 5-day average. Over the past month, the stock has increased by 24.03%, while year-to-date it has risen by 3.61%. However, the stock's performance over the last week shows a slight decline of 0.86%. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, but it is below its 5-day moving average, indicating mixed signals regarding its short-term momentum. In the broader market context, the Sensex has decreased by 1.08% over the past week, which suggests that while Aristo Bio-Tech has faced some challenges, it has managed to perform relatively better than the benchmark. Year-to-date, the Sensex h...

Is Aristo Bio-Tech overvalued or undervalued?

2025-09-24 08:08:14

As of 23 September 2025, the valuation grade for Aristo Bio-Tech has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is considered overvalued based on its current metrics. Key ratios include a PE Ratio of 23.11, an EV to EBITDA of 12.36, and a PEG Ratio of 5.63, all of which suggest that the stock is trading at a premium compared to its earnings growth potential. In comparison to peers, Aristo Bio-Tech's PE Ratio is notably lower than UPL's 38.05 and P I Industries' 34.2, both of which are categorized as attractive or very expensive, respectively. Additionally, while the company has shown a strong one-year return of 35.1%, outperforming the Sensex's decline of 2.97%, the overall valuation metrics suggest that it is not justified at its current price level of 137.80....

Why is Aristo Bio-Tech falling/rising?

2025-09-23 23:43:18

As of 23-Sep, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 137.80, showing no change (0.00%). The stock has outperformed its sector by 1.2% today, but it has experienced a decline of 0.86% over the past week. In terms of moving averages, the stock is performing higher than the 20-day, 50-day, 100-day, and 200-day moving averages, although it is lower than the 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume on 22 September falling by 75% compared to the 5-day average. The stock's year-to-date return stands at 3.61%, while its one-year return is notably higher at 35.10%. Unfortunately, there is no information available regarding positive or negative factors affecting the stock. Broader market context indicates that while Aristo Bio-Tech has shown a strong performance over the past month with a return of 24.03%, the benchmark ...

Is Aristo Bio-Tech overvalued or undervalued?

2025-09-23 08:07:04

As of 22 September 2025, the valuation grade for Aristo Bio-Tech has moved from very expensive to expensive, indicating a slight improvement in its perceived value. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 23.11, an EV to EBITDA of 12.36, and a PEG Ratio of 5.63, which suggest that the stock is trading at a premium compared to its earnings growth potential. In comparison to its peers, Aristo Bio-Tech's PE Ratio is significantly lower than that of UPL, which stands at 38.29, while it is higher than Dhanuka Agritech's PE of 23.75. This places Aristo in a challenging position within the industry, as its valuation does not align favorably with its growth prospects. Additionally, while the stock has outperformed the Sensex over the past year with a return of 26.42% compared to the Sensex's -2.28%, the overall valuation still suggests that Ar...

View All News